
1. diabet med. 2015 feb;32(2):e1-3. doi: 10.1111/dme.12585.

not sweet: autoimmune diabetes mellitus triple therapy chronic
hepatitis c infection.

blanchard e(1), vickers cr, samaras k.

author information: 
(1)diabetes metabolism program, garvan institute medical research, 384
victoria street, darlinghurst nsw 2010, sydney australia.

background: triple therapy pegylated interferon, ribavirin protease
inhibitor proven efficacy hepatitis c infection currently the
standard care. interferon-based therapies been, rarely, associated with
the development type 1 diabetes mellitus, cases yet reported
in triple therapy hepatitis c.
case report: describe case autoimmune type 1 diabetes developing a
23-year-old woman initiation triple therapy chronic hepatitis c
virus infection. patient il-28b gene polymorphism rs12979860 ct
genotype, associated antiviral therapy response also
with diabetes risk liver transplantation hepatitis c.
conclusion: studies required determine individual
characteristics may identify patients risk developing type 1
diabetes treated interferon-based regimens hepatitis c infection.

© 2014 authors. diabetic medicine © 2014 diabetes uk.

doi: 10.1111/dme.12585 
pmid: 25204264  [indexed medline]

